In hepatocellular carcinoma (HCC), UBE2M can stabilize β-catenin and increase the level of its downstream protein cyclin D1 to promote the progression from G0/G1 phase to S phase (Fig. 4) [86]. This evidence concerns the gene UBE2M and hepatocellular carcinoma.